More: Digestive Disease Week (DDW) 2008

DDW 2008: Inflammatory Bowel Disease CME

May 17 - 22, 2008, San Diego, California

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, Digestive Disease Week. Conference news does not receive grant support and is produced independently.

Release Date: June 30, 2008; Valid for credit through June 30, 2009

Credits Available
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™ for physicians

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of Digestive Disease Week. These materials and the related activity are not sanctioned by Digestive Disease Week or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Abbott: No Tagline
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe current strategies in biologic therapy for inflammatory bowel disease, with emphasis on anti-TNF therapies.
  2. Explore new and emerging applications of nonbiologic therapies for inflammatory bowel disease, including applications of immunomodulators and 5-ASA/mesalamine.
Authors and Disclosures

Bret A. Lashner, MD
Disclosure: Bret A. Lashner, MD, has disclosed that he has served on the advisory board of Abbott, Elan, Millennium, Shire, Procter & Gamble, Prometheus, and UCB.


Scott E. Plevy, MD, FACP
Disclosure: Scott E. Plevy, MD, FACP, has disclosed that he has received grants for educational activities from, and served as an advisor or consultant to, Centocor, UCB, Abbott, and Elan.


Maria L. Gaiso, PhD
Disclosure: Maria L. Gaiso, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.